7 results
DEFM14A
LRMR
Larimar Therapeutics Inc
29 Apr 20
Proxy related to merger
3:20pm
to proxy contests and other actions by activist stockholders can be costly and time-consuming, and could disrupt Zafgen’s operations and divert the attention … adversely affect the portion of the combined company that the Zafgen stockholders retain; or (16) activist investors might not approve of the proposed
PRER14A
LRMR
Larimar Therapeutics Inc
10 Apr 20
Preliminary revised proxy
4:38pm
debt, special dividends, stock repurchases or sales of assets or the entire company. Responding to proxy contests and other actions by activist … ; or (16) activist investors might not approve of the proposed transaction. Additionally, forward-looking statements related to Chondrial’s future
PREM14A
taif1r5r9y
6 Mar 20
Preliminary proxy related to merger
5:32pm
- Prev
- 1
- Next